AstraZeneca to publish full U.S. trial results after rare rebuke over 'outdated' data

AstraZeneca to publish full U.S. trial results after rare rebuke over 'outdated' data The rare public rebuke marks the latest setback for the vaccine once hailed as a milestone in the fight against the Covid-19 pandemic that has since been dogged by questions over its effectiveness and possible side effects. https://ift.tt/eA8V8J